{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:45:41Z","timestamp":1773013541827,"version":"3.50.1"},"reference-count":12,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DD&amp;T"],"published-print":{"date-parts":[[2024,8,31]]},"DOI":"10.5582\/ddt.2024.01049","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T22:11:43Z","timestamp":1724537503000},"page":"260-264","source":"Crossref","is-referenced-by-count":2,"title":["Determination of anamorelin concentration in human plasma using a simple high-performance liquid chromatography-ultraviolet detection method"],"prefix":"10.5582","volume":"18","author":[{"given":"Takeo","family":"Yasu","sequence":"first","affiliation":[{"name":"Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo, Japan."},{"name":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanami","family":"Iwatuki","sequence":"additional","affiliation":[{"name":"Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Gando","sequence":"additional","affiliation":[{"name":"Department of Medicinal Therapy Research, Education and Research Unit for Comprehensive Clinical Pharmacy, Meiji Pharmaceutical University, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Matumoto","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Meiji Pharmaceutical University, Tokyo, Japan."},{"name":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Masuo","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Shirota","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Tokyo Metropolitan Toshima Hospital, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan."},{"name":"Bokutoh Hospital-Meiji Pharmaceutical University Joint Research Center, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Guillory B, Splenser A, Garcia J. The role of ghrelin in anorexia-cachexia syndromes. Vitam Horm. 2013; 92:61-106.","DOI":"10.1016\/B978-0-12-410473-0.00003-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Anker MS, Holcomb R, Muscaritoli M, von Haehling S, Haverkamp W, Jatoi A, Morley JE, Strasser F, Landmesser U, Coats AJS, Anker SD. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019; 10:22-34.","DOI":"10.1002\/jcsm.12402"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016; 17:519-531.","DOI":"10.1016\/S1470-2045(15)00558-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol. 2017; 28:1949-1956.","DOI":"10.1093\/annonc\/mdx192"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhang H, Garcia JM. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. Expert Opin Pharmacother. 2015; 16:1245-1253.","DOI":"10.1517\/14656566.2015.1041500"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tascilar M, de Jong FA, Verweij J, Mathijssen RH. Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist. 2006; 11:732-741.","DOI":"10.1634\/theoncologist.11-7-732"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Takayama K, Kojima A, Honda C, Nakayama M, Kanemata S, Endo T, Muro K. Real-world safety and effectiveness of anamorelin for cancer cachexia: interim analysis of post-marketing surveillance in Japan. Cancer Med. 2024; 13:e7170.","DOI":"10.1002\/cam4.7170"},{"key":"8","unstructured":"8. US DHHS, FDA, CDER, CVM. Guidance for Industry: Bioanalytical method validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine, Rockville, MD, 2018."},{"key":"9","unstructured":"9. Ono Pharmaceutical Co., Ltd. The drug interview form of Anamorelin Hydrochloride (Edurmiz<sup>\u00ae<\/sup>) (February. 2023 version). <i>https:\/\/www.ono-oncology.jp\/system\/files\/2023-04\/ADM_IF_0_0.pdf<\/i> (accessed Jun 15, 2024). (in Japanese)"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Leese PT, Trang JM, Blum RA, de Groot E. An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin. Clin Pharmacol Drug Dev. 2015; 4:112-120.","DOI":"10.1002\/cpdd.175"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Garcia JM, Polvino WJ. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Horm IGF Res. 2009; 19:267-273.","DOI":"10.1016\/j.ghir.2008.12.003"},{"key":"12","unstructured":"12. Blum R, Polvino W. Pharmacokinetic (PK) profile of RC-1291, a novel oral ghrelin mimetic for the treatment of cancer anorexia\/cachexia. Support Care Cancer. 2006; 14:3-10."}],"container-title":["Drug Discoveries &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/4\/18_2024.01049\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T04:21:12Z","timestamp":1726892472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ddt\/18\/4\/18_2024.01049\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5582\/ddt.2024.01049","relation":{},"ISSN":["1881-7831","1881-784X"],"issn-type":[{"value":"1881-7831","type":"print"},{"value":"1881-784X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,31]]},"article-number":"2024.01049"}}